Whalen HR et al. |
High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime. |
2017 |
Transplantation |
pmid:26950724
|
de Fijter JW et al. |
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial. |
2017 |
Am. J. Transplant. |
pmid:28027625
|
Kabat-Koperska J et al. |
Birth defects in juvenile Wistar rats after exposure to immunosuppressive drugs during pregnancy. |
2017 |
Histol. Histopathol. |
pmid:27097725
|
Elens L and Haufroid V |
Genotype-based tacrolimus dosing guidelines: with or without CYP3A4*22? |
2017 |
Pharmacogenomics |
pmid:29095105
|
Ma X et al. |
Inhibition effect of tacrolimus and platelet-derived growth factor-BB on restenosis after vascular intimal injury. |
2017 |
Biomed. Pharmacother. |
pmid:28633129
|
Li Y et al. |
[Study on the Effect of Immunosuppressive Agent FK506 on Growth and Migration of Lung Cancer Cell]. |
2017 |
Zhongguo Fei Ai Za Zhi |
pmid:28738959
|
Nakamura Y et al. |
Successful Treatment of Behçet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation. |
2017 |
Intern. Med. |
pmid:28502936
|
Sanghavi K et al. |
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients. |
2017 |
Pharmacogenomics J. |
pmid:26667830
|
Heemann U and Viklicky O |
Is trough level variability the new tool for identifying patients at risk for rejection after transplantation? |
2017 |
Nephrol. Dial. Transplant. |
pmid:28186537
|
Størset E et al. |
Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'. |
2017 |
Br J Clin Pharmacol |
pmid:28374426
|
Lawrance IC et al. |
Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis. |
2017 |
Clin. Gastroenterol. Hepatol. |
pmid:28286194
|
Morita M et al. |
The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report. |
2017 |
Odontology |
pmid:27368962
|
Shimizu S et al. |
Reduction of FR900525 using an S-(2-aminoethyl) l-cysteine-resistant mutant. |
2017 |
J. Biosci. Bioeng. |
pmid:28185832
|
Nishiya Y et al. |
A new efficient method of generating photoaffinity beads for drug target identification. |
2017 |
Bioorg. Med. Chem. Lett. |
pmid:28108248
|
Ak K et al. |
Tacrolimus-Eluting Suture Inhibits Neointimal Hyperplasia: An Experimental In Vivo Study in Rats. |
2017 |
Eur J Vasc Endovasc Surg |
pmid:28065442
|
MartÃn-Fernández M et al. |
Effects of Cyclosporine, Tacrolimus, and Rapamycin on Osteoblasts. |
2017 |
Transplant. Proc. |
pmid:29149986
|
Tremblay S and Alloway RR |
Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations. |
2017 |
AAPS J |
pmid:28717926
|
Chen P et al. |
Dynamic effects of CYP3A5 polymorphism on dose requirement and trough concentration of tacrolimus in renal transplant recipients. |
2017 |
J Clin Pharm Ther |
pmid:27885697
|
Zhang W et al. |
Isoglycyrrhizinate Magnesium Enhances Hepatoprotective Effect of FK506 on Ischemia-Reperfusion Injury Through HMGB1 Inhibition in a Rat Model of Liver Transplantation. |
2017 |
Transplantation |
pmid:28885495
|
Burbulla LF et al. |
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease. |
2017 |
Science |
pmid:28882997
|